NANOVIRICIDES, INC. — Director's Dealing 2015

Aug 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2015-08-13

Reporting Person: BONIUK MILTON (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-13	Common Stock, par value $0.001	P	800	$1.25	Acquired	1606191	Direct
2015-08-14	Common Stock, par value $0.001	P	8594	$1.25	Acquired	1614785	Direct
2015-08-17	Common Stock, par value $0.001	P	5244	$1.25	Acquired	1620029	Direct
2015-08-18	Common Stock, par value $0.001	P	2547	$1.25	Acquired	1622576	Direct
2015-08-19	Common Stock, par value $0.001	P	300	$1.25	Acquired	1622876	Direct
2015-08-20	Common Stock, par value $0.001	P	2662	$1.25	Acquired	1625538	Direct
2015-08-21	Common Stock, par value $0.001	P	29853	$1.25	Acquired	1655391	Direct

Footnotes

F1: Includes 1,083,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife. Does not include: 942,859 shares of Common Stock, warrants to purchase an additional 285,714 shares of Common Stock or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; 571,431 shares of Common Stock held by the Boniuk Charitable Foundation; or 50,000 shares of Common Stock, 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.